RFG Advisory’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$626K Sell
1,189
-143
-11% -$80.2K 0.01% 722
2026
Q1
$748K Sell
1,332
-1,299
-49% -$833K 0.01% 619
2025
Q4
$1.78M Sell
2,631
-56
-2% -$38.1K 0.03% 360
2025
Q3
$1.72M Sell
2,687
-4,089
-60% -$2.48M 0.04% 357
2025
Q2
$3.63M Buy
6,776
+366
+6% +$175K 0.09% 185
2025
Q1
$2.69M Buy
+6,410
New +$2.78M 0.07% 207
2024
Q4
Sell
-1,161
Closed -$587K 788
2024
Q3
$587K Sell
1,161
-25
-2% -$12.1K 0.02% 474
2024
Q2
$578K Sell
1,186
-46
-4% -$23.1K 0.02% 458
2024
Q1
$665K Sell
1,232
-24
-2% -$13.1K 0.02% 443
2023
Q4
$697K Buy
1,256
+230
+22% +$108K 0.03% 382
2023
Q3
$449K Buy
1,026
+69
+7% +$34.4K 0.02% 423
2023
Q2
$481K Sell
957
-79
-8% -$37.9K 0.02% 429
2023
Q1
$518K Buy
1,036
+6
+0.6% +$2.87K 0.03% 404
2022
Q4
$497K Buy
1,030
+99
+11% +$38.4K 0.03% 405
2022
Q3
$356K Sell
931
-35
-4% -$12.9K 0.02% 448
2022
Q2
$394K Sell
966
-155
-14% -$63.2K 0.02% 402
2022
Q1
$613K Sell
1,121
-26
-2% -$13.7K 0.04% 279
2021
Q4
$755K Sell
1,147
-2
-0.2% -$1.26K 0.05% 236
2021
Q3
$715K Sell
1,149
-79
-6% -$53.1K 0.06% 223
2021
Q2
$776K Sell
1,228
-57
-4% -$31.5K 0.07% 205
2021
Q1
$629K Buy
1,285
+11
+0.9% +$5.51K 0.07% 217
2020
Q4
$654K Buy
1,274
+35
+3% +$15.7K 0.09% 200
2020
Q3
$487K Buy
1,239
+114
+10% +$42.1K 0.07% 230
2020
Q2
$371K Buy
1,125
+224
+25% +$64.9K 0.06% 248
2020
Q1
$218K Buy
+901
New +$235K 0.04% 308

Other funds holding IDXX

RFG Advisory's IDXX Position: Q2 2026 in Review

RFG Advisory reduced its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, selling an estimated $80.2K and leaving 1,189 shares worth $626K. The position accounts for 0.01% of the portfolio, ranked #722.

RFG Advisory first reported a position in IDXX in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.63M in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • RFG Advisory held 1,189 shares of Idexx Laboratories worth $626K as of Q2 2026.
  • RFG Advisory sold 143 Idexx Laboratories shares in Q2 2026, an estimated $80.2K.
  • Idexx Laboratories made up 0.01% of RFG Advisory's portfolio in Q2 2026, its #722 holding.
  • RFG Advisory first reported a position in Idexx Laboratories in Q1 2020 and has held it in 25 quarters since.
  • RFG Advisory's Idexx Laboratories position peaked at $3.63M in Q2 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.